Where does Carl Gordon work?

Carl Gordon is Managing Partner at OrbiMed and Founder at Belenos Biosciences and Founder at Alterome Therapeutics, Inc. and Founder at Odyssey Therapeutics.

What check size does Carl Gordon write?

Carl Gordon typically writes checks of $1M – $75M.

Carl Gordon

InvestorFounder

Managing Partner at OrbiMed · Board director at Belenos Biosciences · Board director at Alterome Therapeutics, Inc. · Board director at Odyssey Therapeutics

New York City Metropolitan Area

Writes $1M – $75M checks · typically $4M

FoundedAdicet Bio Alterome Therapeutics, Inc.Belenos Biosciences Gemini Therapeutics Igenica Biotherapeutics Kumquat Biosciences

Midas 2020 · #77 Midas 2019 · #14 Midas 2018 · #4 Midas 2017 · #8 Midas 2016 · #20 Midas 2015 · #89 Midas 2014 · #64

About

Carl Gordon, an MIT Ph.D. and CFA with early hands‑on ImClone experience, is a founding GP and Co‑Head of global private equity repeatedly named to Forbes' Midas List and media‑shy.

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Board director at Belenos Biosciences

Intro paths

→

In turn, Carl can intro founders to Belenos Biosciences's investors below.

Belenos Biosciences's investors · 1

OrbiMedNew York · $1M – $75M checks · since 2024

Co-founders at Belenos Biosciences

Tania DimitrovaExecutive Officer

Megan DowExecutive Officer

StJohn Donnie McGrathExecutive Officer, Director

Board director at Alterome Therapeutics, Inc.

Intro paths

→

In turn, Carl can intro founders to Alterome Therapeutics, Inc.'s investors below.

Alterome Therapeutics, Inc.'s investors · 5

Canaan PartnersStamford · $500K – $20M checks · since 2021 Digitalis VenturesNew York · $100K – $10M checks · since 2021 Nextech InvestZurich · $648K – $3.2M checks · since 2021 OrbiMedNew York · $1M – $75M checks · since 2021 Vida VenturesLos Angeles · since 2021

Co-founders at Alterome Therapeutics, Inc.

Eric A. MurphyExecutive Officer, Director, Promoter

Ryan B. CorcoranDirector, Promoter

Board director at Odyssey Therapeutics

Intro paths

→

In turn, Carl can intro founders to Odyssey Therapeutics's investors below.

Odyssey Therapeutics's investors · 13

Activant CapitalNew York · $100K – $50M checks Ascenta CapitalWilmington · since 2023 Balderton CapitalLondon · $5M – $50M checks Catalio Capital Management, LPNew York Dimension CapitalSan Francisco · $1M – $10M checks · since 2025 Foresite CapitalLarkspur Global BioAccess FundNew York · $10M checks GreatPoint VenturesSan Francisco · $250K – $20M checks Jeito CapitalParis · since 2025 Lightspeed Venture PartnersMenlo Park · $1.7M – $87M checks OrbiMedNew York · $1M – $75M checks Sanofi VenturesCambridge · $5M checks SR One Capital ManagementRedwood City · since 2025

Co-founders at Odyssey Therapeutics

Gary D GlickExecutive Officer, Director

Experience

OrbiMed AdvisorsManaging Partnercurrent2018 — present
OrbiMed AdvisorsFounding General Partner1998 — 2018
Mehta and IsalyBiotechnology Analyst1995 — 1997New York
The Rockefeller UniversityPostdoctoral Fellow1993 — 1995New York
Imclone SystemsComputational Biology1987 — 1988New York

Education

Massachusetts Institute of TechnologyPh.D., Department of Biology1988 — 1993
Harvard UniversityBachelor's degree, Chemistry & Physics1983 — 1987
Munster High School1979 — 1983

Deals · 9

Belenos BiosciencesBoard seat

via OrbiMed · filed Jul 2024 · $55M raise

Theseus PharmaceuticalsBoard seat

via OrbiMed · filed Feb 2021 · $22.1M raise

Compass TherapeuticsBoard seat

via OrbiMed · filed Jul 2020 · $195.3M raise

Keros TherapeuticsBoard seat

via OrbiMed · filed Mar 2020 · $56M raise

SpringWorks TherapeuticsBoard seat

via OrbiMed · filed Apr 2019 · $125M raise

Adicet BioBoard seat

via OrbiMed · filed Oct 2018 · $43.3M raise

Prevail TherapeuticsBoard seat

via OrbiMed · filed Mar 2018 · $65M raise

Gemini TherapeuticsBoard seat

via OrbiMed · filed May 2016 · $2M raise

Igenica BiotherapeuticsBoard seat

via OrbiMed · filed Jan 2015 · $6.3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at OrbiMed

Venture Partner at OrbiMed

Andrew P. Kanarek, CFA, CIPM

Network9

Peter ThielScout

Co-founder & Partner at Founders Fund

Liam RatcliffeScout

General Partner at New Leaf Venture Partners

Phil FerneauScout

Managing Partner at Borealis Ventures

Terry McGuireScout

Founding Partner at Polaris Partners

Beth Seidenberg

Founding Managing Director at Westlake Village BioPartners

Jason P. Hafler

Managing Director at Sanofi Ventures

Maha Katabi

General Partner at Sofinnova Ventures

Michael Rome

Managing Director at Foresite Capital

Mona Ashiya

General Partner at OrbiMed

Investors connected to Carl in public investor directories — a warm-intro map.

Frequently asked questions

Where does Carl Gordon work?: Carl Gordon is Managing Partner at OrbiMed and Founder at Belenos Biosciences and Founder at Alterome Therapeutics, Inc. and Founder at Odyssey Therapeutics.
What does Carl Gordon invest in?: Carl Gordon invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
What check size does Carl Gordon write?: Carl Gordon typically writes checks of $1M – $75M.
What companies did Carl Gordon found?: Carl Gordon founded Adicet Bio, Alterome Therapeutics, Inc., Belenos Biosciences, Gemini Therapeutics, Igenica Biotherapeutics, Kumquat Biosciences.